EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Comparative Safety of Different Antibiotic Regimens for the Treatment of Outpatient Community-Acquired Pneumonia Among Otherwise Healthy Adults

Anne M Butler iD, Katelin B Nickel iD, Margaret A Olsen iD, John M Sahrmann iD, Ryan Colvin iD, Elizabeth Neuner, Caroline A O'Neil iD, Victoria J Fraser iD, Michael J Durkin, CDC Prevention Epicenters Program

Clinical Infectious Diseases · 2026

DOI: 10.1093/cid/ciae519 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Anne M Butler und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Community-Acquired Infections, Anti-Bacterial Agents, Pneumonia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, AHRQ HHS, NCEZID CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Evidence is limited on the comparative safety of antibiotic regimens for treatment of community-acquired pneumonia (CAP). We compared the risk of adverse drug events (ADEs) associated with antibiotic regimens for CAP treatment among otherwise healthy, nonelderly adults.

Methods

We conducted an active-comparator new-user cohort study (2007–2019) of commercially insured adults aged 18–64 years diagnosed with outpatient CAP, evaluated via chest X-ray, and dispensed a same-day CAP-related oral antibiotic regimen. ADE follow-up duration ranged from 2 to 90 days (eg, renal failure [14 days]). We estimated risk differences [RDs] per 1000 treatment episodes and risk ratios using propensity score–weighted Kaplan-Meier functions. Ankle/knee sprain and influenza vaccination were considered as negative control outcomes.

Results

Of 145 137 otherwise healthy CAP patients without comorbidities, 52% received narrow-spectrum regimens (44% macrolide, 8% doxycycline) and 48% received broad-spectrum regimens (39% fluoroquinolone, 7% β-lactam, 3% β-lactam + macrolide). Compared with macrolide monotherapy, each broad-spectrum antibiotic regimen was associated with increased risk of several ADEs (eg, β-lactam: nausea/vomiting/abdominal pain [RD per 1000, 3.20; 95% CI, 0.99–5.73]; non–Clostridioides difficile diarrhea [RD per 1000, 4.61; 95% CI, 2.47–6.82]; vulvovaginal candidiasis/vaginitis [RD per 1000, 3.57; 95% CI, 0.87, 6.88]). Narrow-spectrum antibiotic regimens largely conferred similar risk of ADEs. We generally observed similar risks of each negative control outcome, indicating minimal confounding.

Conclusions

Broad-spectrum antibiotics were associated with increased risk of ADEs among otherwise healthy adults treated for CAP in the outpatient setting. Antimicrobial stewardship is needed to promote judicious use of broad-spectrum antibiotics and ultimately decrease antibiotic-related ADEs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Community-Acquired InfectionsAnti-Bacterial AgentsPneumoniaHumansAdultFemaleMaleMiddle AgedYoung AdultAdolescentOutpatientsCohort StudiesMacrolidesCommunity-Acquired Pneumonia

Stichwörter der Autor:innen

administrative dataadverse drug eventsantibiotic safetyantimicrobial stewardshipcommunity-acquired pneumonia

Substanzen

Anti-Bacterial AgentsMacrolides

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Department of Pharmacy, Barnes-Jewish Hospital, St. Louis, Missouri, USA.

ORCID-Profile: Anne M Butler, Katelin B Nickel, Margaret A Olsen, John M Sahrmann, Ryan Colvin, Caroline A O'Neil, Victoria J Fraser

Förderung

  • NCATS NIH HHS
  • AHRQ HHS
  • NCEZID CDC HHS
  • Centers for Disease Control and Prevention, Prevention Epicenters
  • (NCATS)
  • NIH HHS
  • National Center for Advancing Translational Sciences
  • Washington University Institute of Clinical and Translational Sciences

Zitieren

APA

Butler, A. M., Nickel, K. B., Olsen, M. A., Sahrmann, J. M., Colvin, R., Neuner, E., O'Neil, C. A., Fraser, V. J., Durkin, M. J., & CDC Prevention Epicenters Program (2026). Comparative Safety of Different Antibiotic Regimens for the Treatment of Outpatient Community-Acquired Pneumonia Among Otherwise Healthy Adults. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae519

Vancouver

Butler AM, Nickel KB, Olsen MA, Sahrmann JM, Colvin R, Neuner E, et al. Comparative Safety of Different Antibiotic Regimens for the Treatment of Outpatient Community-Acquired Pneumonia Among Otherwise Healthy Adults. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciae519

BibTeX
@article{Butler2026,
  author = {Butler, Anne M and Nickel, Katelin B and Olsen, Margaret A and Sahrmann, John M and Colvin, Ryan and Neuner, Elizabeth and O'Neil, Caroline A and Fraser, Victoria J and Durkin, Michael J and CDC Prevention Epicenters Program, CDC Prevention Epicenters Program},
  title = {Comparative Safety of Different Antibiotic Regimens for the Treatment of Outpatient Community-Acquired Pneumonia Among Otherwise Healthy Adults},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciae519}
}
Kostenlos starten →